Research Abstracts

The Journal of Informed Pharmacotherapy 2002;11:410.

Venous Thromboembolism Prevention in Medical Patients with Congestive Heart Failure or Chronic Obstructive Pulmonary Disease

Rumi Pattar, B.Sc. (Pharm), Zahra Kanji, B.Sc.(Pharm), Pharm.D., Mark Collins, B.Sc.(Pharm), M.Sc.(Pharmacol)

Department of Pharmacy , Lion's Gate Hospital, North Vancouver, British Columbia, Canada

Canadian Society of Hospital Pharmacists (British Columbia Branch) Residency Research Presentation Night, Vancouver, British Columbia, Canada. May 8, 2002.


Objectives

To measure the impact of educational interventions on the utilization of thromboprophylaxis as per current guidelines amongst, patients admitted with an exacerbation of congestive heart disease (CHF) or chronic obstructive pulmonary disease (COPD).

Setting

A Canadian community hospital.

Design

Educational interventions in the form of presentations and memos were undertaken in conjunction with 2 physicians to disseminate the findings of venous thromboembolism (VTE) prophylaxis utilization amongst CHF and COPD patients admitted to Lions Gate Hospital and to educate physicians, pharmacists and nurses regarding current practice guidelines for VTE prophylaxis in medical patients. A retrospective analysis of patients admitted with CHF or COPD during a five-month period was conducted following the educational intervention. Furthermore, all physicians were surveyed regarding perceived barriers to VTE prophylaxis amongst CHF and COPD patients.

Results

Following the educational intervention, 46% (n=28) of patients with CHF and 30% (n=33) of patients with COPD received VTE prophylaxis. The survey results revealed that physicians mainly attributed the low rates of prophylaxis to oversight and unawareness of current guidelines.

Conclusions

There are poor rates of VTE prophylaxis amongst patients with CHF and COPD exacerbations at our institution and educational interventions alone were insufficient to ensure the routine use of prophylaxis in clinical practice.


Copyright © 2002 by the Journal of Informed Pharmacotherapy. All rights reserved.